Potential of more than 20% for seven Ibex 35 shares at the start of 2026

Foto del autor

By Jack Ferson

Potential of more than 20% for seven Ibex 35 shares at the start of 2026

2026 starts after a record 2025 that few analysts and investors had expected. The IBEX 35 recorded a strong rise of almost 50% in the year, the second highest in history, only surpassed by the 54.2% that was recorded in the now distant 1993. In December, the accumulated advance was almost 6%, to historical highs above 17,300 points. But in the Stock Market, as in any other aspect of life, you can’t live from the past. And, as it is never worth remembering, past returns do not guarantee future returns.

Therefore, investors will have to meticulously scrutinize the opportunities that the Ibex 35 continues to offer for this coming year; and there are not few, in the opinion of fundamental analysts. Today, 23 of the 35 components of the IBEX 35 present an upward potential within 12 monthsaccording to data collected by Reuters. In 13 of them the potential is double digits, with 7 with a rise of more than 20% ahead and 2 even exceeding 40%.

The highest potential of the entire index is that presented by Cellnex, and 45.3% up to an average target price that fundamental analysts place at 40.03 euros per share, according to data compiled by Reuters. The stock lagged last year on the IBEX 35, accumulating a drop of almost 10%, but experts seem confident in its long-term strength.

And potential of more than 44% presents Grifols, with the average target price set at 15.45 euros. Unlike Cellnex, the truth is that the blood products company did not have a bad year on the trading floor. Although it fell far short of the market leaders, the accumulated increase in 2025 of 18% was quite solid. Little by little, investors are beginning to leave behind the messes about the company’s accounts that weighed them down in previous years, and analysts expect the stock to stay the course in 2026.

The third step on the podium goes to Puig Brands, to which fundamental analysts give a consensus target price of 19.64 euros, which is 31.8% above of its current price. The company behind Carolina Herrera perfumes has experienced a via crucis since it hit the market in May 2024. The securities were then listed at a price of 24.50 euros, and although experts do not expect it to recover them in the medium term, yes they believe they are unjustifiably cheap.

If the focus is on the best values ​​of the IBEX 35 in 2025, analysts are betting on caution, although there is still some opportunity. Indra, for example, soared more than 180% last year in the heat of the plans of European governments (including the Spanish one) to boost defense spending, but still presents a moderate potential of just over 6% up to a target price of 51.36 euros, which would mean new historical highs.

On the contrary, banks, which were the engine of the IBEX 35 in 2025, seem to have exhausted their potential for the moment. Analysts only see a moderate upward trend of 4% in Banco Sabadell, an entity that lagged a little behind the rest after the slam the door that its shareholders gave to BBVA’s attempted takeover bid.

One factor to take into account is that, after the strong increases last year, there are no less than 12 IBEX 35 values ​​in which analysts expect falls from current levels. And in some cases with some force. The clearest case is that of Mapfre, which after rising more than 80% in 2025 has ahead a drop of 14%according to the consensus of analysts, with an average target price of 3.67 euros. Experts also predict double-digit falls for Unicaja (-11.57%) and Endesa (.10.03%).

Valor Potential at 12 months (%) Profitability 2025 (%) Target Price
Action -9 75,94 168,53 Access Acciona’s analysis
Activate Energy 1,97 28,27 22,82 Access the analysis of Acciona Energía
Acerinox 11,82 41,79 14,1 Access the Acerinox analysis
ACS -8,76 81,34 77,33 Access ACS analysis
Aena 4,33 26,17 24,84 Access Aena’s analysis
Amadeus 22,22 -7,7 76,41 Access Amadeus analysis
ArcelorMittal -9,75 75,67 35 Access ArcelorMittal analysis
Sabadell Bank 4,01 95,91 3,5 Access the analysis of Banco Sabadell

Santander Bank

-4,5 132,9 9,64 Access Santander analysis
Bankinter -3,31 95,14 13,73 Access Bankinter analysis
BBVA -3,04 124,7 19,43 Access BBVA analysis
Caixabank -6,08 112,49 9,81 Access Caixabank analysis
Cellnex 45,3 -9,71 40,03 Access Cellnex analysis
Colonial 26,32 9,98 6,84 Access Colonial analysis
Enagas 13,5 20,81 15,05 Access the Enagas analysis
Endesa -10,03 56,5 27,71 Access Endesa’s analysis
Ferrovial 0,8 38,01 55,66 Access Ferrovial’s analysis
Fluidra 14,93 1,13 26,64 Access Fluidra analysis
Grifols 44,12 18,22 15,45 Access Grifols analysis
IAG (Iberia) 7,8 34,53 5,13 Access IAG analysis
Iberdrola -3,59 45,34 17,87 Access Iberdrola’s analysis
Inditex -0,39 17,88 56,3 Access the Inditex analysis
Indra 6,38 184,28 51,36 Access Indra’s analysis

Rovi Laboratories

29,21 2,61 82,11 Access Rovi analysis
From the log 4,16 10,82 31,33 Access Logista analysis
Mapfre -14,05 82,75 3,67 Access Mapfre analysis

MERLIN Properties

20,66 26,73 14,95 Access Merlin’s analysis

Naturgy (Gas Natural)

4,78 18,81 27,16 Access Naturgy analysis
Puig 31,81 -14,51 19,64 Access Puig’s analysis
Redeia (REE) 12,88 -3,59 17,18 Access Redeia analysis
Repsol 2,63 48,25 16,41 Access Repsol’s analysis
Sacyr 17,36 26,11 4,53 Access Sacyr’s analysis
Solaria 1,13 131,41 18,29 Access Solaria analysis
Telefónica 15,3 -4,18 4,04 Access Telefónica’s analysis
Unicaja Bank -11,57 135,37 2,46 Access Telefónica’s analysis

Source: Reuters

Deja un comentario